Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 – mapping retrospective data
Aurora Jørnsdatter Kojen, Thomas Halvorsen, Astrid Gjelstad, Stig Larsen, Fredrik Lauritzen, Trine Stensrud · 2026
Read Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 – mapping retrospective data by Aurora Jørnsdatter Kojen, Thomas Halvorsen, Astrid Gjelstad, Stig Larsen, Fredrik Lauritzen, Trine Stensrud (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13219012.txt.
Description
Aurora Kojen and colleagues mapped in 2026 the asthma medicines reported by athletes on doping control forms in Norway from twenty fifteen to twenty nineteen. Asthma and airway sensitivity are common in athletes, above all in endurance sports and cold or polluted settings. The forms offer a window on real medication use.
Of more than ten thousand forms, about sixteen percent listed one or more anti-asthmatic drugs. Bronchodilators were most common. Reports ran higher for women, national-level athletes, those in high asthma-risk sports, and the thirty to thirty-four age group. The authors note some athletes appear on several forms, and they call for more research on guideline adherence in sport.
Catalog record
| CREATOR | Aurora Jørnsdatter Kojen, Thomas Halvorsen, Astrid Gjelstad, Stig Larsen, Fredrik Lauritzen, Trine Stensrud |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |